Skip to main content

January 2012 - FRMC

01/25/2012
Although noroviruses are a leading cause of epidemic acute gastroenteritis and sporadic cases of acute gastroenteritis, a reliable vaccine for these types of viruses has not yet been developed, nor has any specific therapy been developed to...
Although noroviruses are a leading cause of epidemic acute gastroenteritis and sporadic cases of acute gastroenteritis, a reliable vaccine for these types of viruses has not yet been developed, nor has any specific therapy been developed to...
Although noroviruses are a...
01/25/2012
First Report Managed Care
01/25/2012
Researchers have known that using biomarkers to facilitate early detection of Alzheimer disease (AD) is crucial for developing potential treatment. Studies have shown that Aβ42 and tau protein levels in cerebrospinal fluid (CSF),...
Researchers have known that using biomarkers to facilitate early detection of Alzheimer disease (AD) is crucial for developing potential treatment. Studies have shown that Aβ42 and tau protein levels in cerebrospinal fluid (CSF),...
Researchers have known that...
01/25/2012
First Report Managed Care
01/25/2012
Madrid—A database analysis of women <50 years of age who received a tubal ligation and had continuous insurance coverage for 1 year after the procedure found that a substantial number of patients experienced complications, which were...
Madrid—A database analysis of women <50 years of age who received a tubal ligation and had continuous insurance coverage for 1 year after the procedure found that a substantial number of patients experienced complications, which were...
Madrid—A database analysis of...
01/25/2012
First Report Managed Care
01/25/2012
Orlando—Enhanced prescription coverage improved medication adherence and rates of first major vascular events and decreased patient spending without increasing overall health costs when eliminating medication copays for patients following...
Orlando—Enhanced prescription coverage improved medication adherence and rates of first major vascular events and decreased patient spending without increasing overall health costs when eliminating medication copays for patients following...
Orlando—Enhanced prescription...
01/25/2012
First Report Managed Care
01/25/2012
Orlando—The ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial found that treatment with 30 days of oral apixaban is no more effective than 1 to 2 weeks of injected enoxaparin for preventing venous thromboembolism (VTE) in...
Orlando—The ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial found that treatment with 30 days of oral apixaban is no more effective than 1 to 2 weeks of injected enoxaparin for preventing venous thromboembolism (VTE) in...
Orlando—The ADOPT (Apixaban...
01/25/2012
First Report Managed Care
01/25/2012
Orlando—A follow-up analysis of a phase 3 trial found that patients with very high triglyceride levels who took 4 g/day of AMR101 had a significant reduction in the lipoprotein concentrations of the large very-low-density lipoprotein (VLDL),...
Orlando—A follow-up analysis of a phase 3 trial found that patients with very high triglyceride levels who took 4 g/day of AMR101 had a significant reduction in the lipoprotein concentrations of the large very-low-density lipoprotein (VLDL),...
Orlando—A follow-up analysis of...
01/25/2012
First Report Managed Care

Department

News Connection
01/25/2012
Although methicillin resistance is common in Staphylococcus aureus in hospitals, the presence of such resistance in the community is also increasingly reported. It is commonly referred to as community-associated methicillin-resistant...
Although methicillin resistance is common in Staphylococcus aureus in hospitals, the presence of such resistance in the community is also increasingly reported. It is commonly referred to as community-associated methicillin-resistant...
Although methicillin resistance...
01/25/2012
First Report Managed Care
News Connection
01/25/2012
A family history (FH) of Alzheimer’s disease (AD) is linked to preclinical abnormalities in disease biomarkers, independent of the risk conferred by the apolipoprotein E (APOE) susceptibility gene in cognitively normal middle- to older-aged...
A family history (FH) of Alzheimer’s disease (AD) is linked to preclinical abnormalities in disease biomarkers, independent of the risk conferred by the apolipoprotein E (APOE) susceptibility gene in cognitively normal middle- to older-aged...
A family history (FH) of...
01/25/2012
First Report Managed Care
Conference Insider
01/25/2012
Orlando—The anticlotting drug rivaroxaban added to standard medical treatment lowered the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in acute coronary syndrome (ACS) patients, but was associated with an increase...
Orlando—The anticlotting drug rivaroxaban added to standard medical treatment lowered the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in acute coronary syndrome (ACS) patients, but was associated with an increase...
Orlando—The anticlotting drug...
01/25/2012
First Report Managed Care

News

News
01/25/2012
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an...
01/25/2012
First Report Managed Care